COVID-19 clinical trials lack diversity

Trials need more Black, Indigenous and people of color to generalize results to larger U.S. population

Despite disproportionately higher rates of COVID-19 infection, hospitalization and death among people of color, minority groups are significantly underrepresented in COVID-19 clinical trials, according to a new perspective authored by faculty from the University of Georgia and University of Colorado and pharmacists from Phoebe Putney Memorial Hospital in Albany.

Published by the New England Journal of Medicine, the article calls on government agencies, medical journals, funders of research, among others, to diversify study participants in order to be able to generalize results to the larger U.S. population. Lead author is Daniel Chastain, a clinical assistant professor of pharmacy at UGA’s Albany campus. Co-authors also include Sharmon Osae and Henry Young from the UGA College of Pharmacy and Joeanna Chastain from Phoebe.

Story continues ... >>

 

About Us

At Women in Science, our goal is to build a supportive community to connect women who are in science / STEM fields. We are dedicated to promoting recruitment and retention of women in science, and to enlisting companies and institutions for a broad coalition of educators and employers to help bring down the barriers and empower women in their chosen fields. Find more info ... >>

Contact info

WomenInScience.com
9951 ATLANTIC BLVD., STE 105
JACKSONVILLE, FL 32225
U.S.A.
Email: staff@womeninscience.com
Phone: (904) 638-1058
Fax: (904) 212-1238

Career Network

www.postdocjobs.comwww.stemcareers.com